46 matches found
John Glass, PhD J. Craig Venter Institute; Professor and Leader of the Synthetic Biology & Bioenergy Group
There are significant concerns about the reproducibility of scientific results across many fields including neuroimaging. This talk will discuss the source of these problems and outline a set of approaches to improve the reproducibility of neuroimaging research.
"Even a Moon Shot Needs a Flight Plan: Genetics and Ethics in the Obama Administration" Dr. Alondra Nelson President, Social Science Research Council Harold F. Linder Professor, Institute for Advanced Study, Princeton
Jay Keasling, PhD University of California Berkeley College of Chemistry; Professor, Department of Chemical & Biomolecular Engineering and Professor, Department of Bioengineering
Converging Paths: My Career as a Scientist and an Entrepreneur Monday, October 14th at 12:00pm in 612 IGB Dr. Penelope Shihab CEO and Founder, Monojo Biotech; Skinue.com; Applied Scientific Research Fund
Fox Family Innovation and Entrepreneurship Lecture "Turning Science Into Social Impact: How We Built A Computational Genomics Operating System for Treating Cancer" Kevin White, PhD President of Tempus Labs Inc.; Professor, Department of Human Genetics and Medicine, University of Chicago
The last few years has seen rapid progress in the discovery of genes underlying risk for severe mental illness, Research in the Ament lab aims to trace mechanisms from genes to brain to mental illness through human genetics, stem cell models of brain development, and single-cell genomics.
John F. Allen Research Department of Genetics, Evolution and Environment University College London "Why have chloroplasts and mitochondria retained genomes?"
"Genetic Studies of Autism Spectrum Disorders: Family-based Approach" Maja Bucan, PhD University of Pennsylvania Perelman School of Medicine; Professor, Department of Genetics
“Life Innovates, Biology Integrates: A Vision for the Biological Sciences” Dr. Joanne Tornow Assistant Director for Biological Sciences, National Science Foundation Reception immediately following, sponsored by the Catherine and Don Kleinmuntz Center for Genomics in Business and Society
Trudy Mackay, PhD Clemson University; Professor, Department of Genetics and Biochemistry
There has been a surge in technologies to observe how genes and proteins change in the brain during disease. I will describe a new method, DART (drugs acutely restricted by tethering), to rapidly restrict drugs to genetically defined neurons in behaving mice. The approach offers a new way to establish causal circuit and molecular substrates of normal and aberrant behavior.
"The Antimicrobial Resistance Crisis: How NIAMRRE Supports Solutions" Dr. Kristen Obbink, DVM, MPH Associate Director, National Institute of Antimicrobial Resistance Research and Education (NIAMRRE), Iowa State University